New Mountain Capital Makes Majority Investment in Covaris

January 13, 2022

New Mountain Capital has made a majority investment in Covaris, a Woburn, Massachusetts-based manufacturer of sample preparation instruments, consumables and reagents for genomics and proteomics. Founder Jim Laugharn will remain CEO and Chris O'Connell will serve as Executive Chairman as New Mountain partners with Covaris to accelerate growth and expand the company's sample-prep capabilities.

Buyers
New Mountain Capital
Targets
Covaris, Inc.
Industry
Medical Devices
Location
Massachusetts, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.